Neurotech International Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Anthony Filippis
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.8yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Here's Why We're A Bit Worried About Neurotech International's (ASX:NTI) Cash Burn Situation
Mar 05
Why Neurotech International Limited (ASX:NTI) Could Be Worth Watching
Nov 19Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans
Sep 19Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
Jan 28We Think Neurotech International (ASX:NTI) Needs To Drive Business Growth Carefully
Oct 14Here's Why We're Not Too Worried About Neurotech International's (ASX:NTI) Cash Burn Situation
Jul 01Is Neurotech International (ASX:NTI) In A Good Position To Invest In Growth?
Jan 21Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?
Oct 06Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
May 18We're Not Very Worried About Neurotech International's (ASX:NTI) Cash Burn Rate
Dec 21Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans
Sep 04Need To Know: Neurotech International Limited (ASX:NTI) Insiders Have Been Selling Shares
Dec 08
CEO
Anthony Filippis
Dr. Anthony Filippis, BSc (Hons.), PhD, MBA, serves as Managing Director, CEO and Director at Neurotech International Limited since February 01, 2025. He serves as Chief Operating Officer at Percheron Ther...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Operating Officer | 2.8yrs | AU$36.51k | no data | |
| Director of Public Relations & Director | 2.9yrs | AU$136.55k | 0.026% A$ 5.8k | |
| MD, CEO & Director | less than a year | no data | no data | |
| Chief Scientific Officer & Member of Scientific Advisory Board | 6.8yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Chief Medical Advisor for USA | less than a year | no data | no data | |
| Chief Executive Officer of AAT Research Ltd | 4.8yrs | AU$109.03k | no data | |
| Company Secretary | no data | no data | no data |
Experienced Management: NTI's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director of Public Relations & Director | 3yrs | AU$136.55k | 0.026% A$ 5.8k | |
| MD, CEO & Director | less than a year | no data | no data | |
| Chief Scientific Officer & Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 6.8yrs | no data | no data | |
| Director | 1.3yrs | AU$34.05k | 0.098% A$ 21.7k | |
| Independent Non-Executive Chairman | 6.3yrs | AU$61.22k | 1.12% A$ 247.7k | |
| Chairman of Scientific Advisory Board (Currently Dormant) | 8.6yrs | AU$34.71k | no data | |
| Member of Scientific Advisory Board | 6.8yrs | no data | no data |
Experienced Board: NTI's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/22 14:38 |
| End of Day Share Price | 2025/07/22 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Neurotech International Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew Goodsall | MST Financial Services Pty Limited |